Daniela Wenge, M.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myeloid-Lymphoid Leukemia Protein | 5 | 2024 | 305 | 1.350 |
Why?
|
Leukemia | 2 | 2023 | 1522 | 0.620 |
Why?
|
Histone-Lysine N-Methyltransferase | 3 | 2024 | 682 | 0.510 |
Why?
|
Hodgkin Disease | 1 | 2021 | 1378 | 0.430 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2024 | 3613 | 0.310 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5671 | 0.260 |
Why?
|
Phthalimides | 1 | 2024 | 34 | 0.230 |
Why?
|
Piperidones | 1 | 2024 | 37 | 0.230 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2024 | 163 | 0.220 |
Why?
|
Transplantation, Homologous | 2 | 2021 | 4806 | 0.200 |
Why?
|
Morpholines | 1 | 2024 | 581 | 0.180 |
Why?
|
Antibodies, Bispecific | 1 | 2020 | 196 | 0.150 |
Why?
|
Proto-Oncogene Proteins | 3 | 2024 | 4511 | 0.140 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2024 | 1606 | 0.130 |
Why?
|
Transplantation Conditioning | 1 | 2021 | 1590 | 0.110 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 1600 | 0.100 |
Why?
|
Mutation | 4 | 2024 | 30052 | 0.100 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6814 | 0.090 |
Why?
|
Proteomics | 1 | 2023 | 3849 | 0.090 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5796 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2023 | 5305 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2024 | 1551 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9280 | 0.050 |
Why?
|
Chromatin | 2 | 2024 | 2960 | 0.050 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2024 | 651 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11742 | 0.040 |
Why?
|
Mice, SCID | 1 | 2024 | 2626 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2024 | 16981 | 0.040 |
Why?
|
Humans | 8 | 2024 | 761504 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3602 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2021 | 80636 | 0.030 |
Why?
|
Binding Sites | 1 | 2023 | 6055 | 0.030 |
Why?
|
Transcription Factors | 2 | 2024 | 12128 | 0.030 |
Why?
|
Mice | 3 | 2024 | 81525 | 0.030 |
Why?
|
Animals | 4 | 2024 | 168459 | 0.020 |
Why?
|
Gene Expression | 1 | 2023 | 7581 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2024 | 13639 | 0.020 |
Why?
|
Protein Binding | 1 | 2023 | 9351 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2024 | 10445 | 0.020 |
Why?
|
Young Adult | 1 | 2020 | 59243 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 88319 | 0.010 |
Why?
|
Aged | 1 | 2020 | 169289 | 0.000 |
Why?
|
Middle Aged | 1 | 2020 | 220895 | 0.000 |
Why?
|
Adult | 1 | 2020 | 221177 | 0.000 |
Why?
|
Male | 1 | 2020 | 360804 | 0.000 |
Why?
|
Female | 1 | 2020 | 392644 | 0.000 |
Why?
|